Exploring Non-orthosteric Interactions with a Series of Potent and Selective A 3 Antagonists

• Published in: ACS medicinal chemistry letters Vol. 13; no. 2; pp. 243 - 249
• Main Authors: Miranda-Pastoriza, Darío, Bernárdez, Rodrigo, Azuaje, Jhonny, Prieto-Díaz, Rubén, Majellaro, Maria, Tamhankar, Ashish V, Koenekoop, Lucien, González, Alejandro, Gioé-Gallo, Claudia, Mallo-Abreu, Ana, Brea, José, Loza, M Isabel, García-Rey, Aitor, García-Mera, Xerardo, Gutiérrez-de-Terán, Hugo, Sotelo, Eddy
• Format: Journal Article
• Language: English
• Published: United States 10-02-2022
• ISSN: 1948-5875; 1948-5875
• DOI: 10.1021/acsmedchemlett.1c00598

A library of potent and highly A
AR selective pyrimidine-based compounds was designed to explore non-orthosteric interactions within this receptor. Starting from a prototypical orthosteric A
AR antagonist (ISVY130), the structure-based design explored functionalized residues at the exocyclic amide L1 region and aimed to provide additional interactions outside the A
AR orthosteric site. The novel ligands were assembled through an efficient and succinct synthetic approach, resulting in compounds that retain the A
AR potent and selective profile while improving the solubility of the original scaffold. The experimentally demonstrated tolerability of the L1 region to structural functionalization was further assessed by molecular dynamics simulations, giving hints of the non-orthosteric interactions explored by these series. The results pave the way to explore newly functionalized A
AR ligands, including covalent drugs and molecular probes for diagnostic and delivery purposes.